Panzyga (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Panzyga, is an immunoglobulin presented as a 10% solution for intravenous use. It treats primary immunodeficiency diseases and provides immune support in patients with antibody deficiencies. GNH USA supplies Panzyga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Panzyga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Panzyga is an immunoglobulin used in the management of disorders that affect the immune system.

- Primary immunodeficiency diseases: Replaces missing antibodies and reduces infection frequency. - Secondary immunodeficiency conditions: Provides passive immunity to patients with compromised antibody production. - Post‑exposure prophylaxis: Supplies an immediate source of antibodies after exposure to certain infections. - Immunomodulation: Helps modulate immune responses in selected autoimmune or inflammatory conditions. - Supportive therapy for bone‑marrow transplant : Aids the patient in immune reconstitution after transplant. - Hematologic disorders : Provides temporary immune support during treatment of certain blood disorders.

Panzyga         …  … … … … ... ... … … …  t   t.

Common   g   t  g   ewline

t  ewline  \n    ewline  

ewline  ewline  ewline  ewline ",